1. Home
  2. INDP vs CNVS Comparison

INDP vs CNVS Comparison

Compare INDP & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • CNVS
  • Stock Information
  • Founded
  • INDP 2000
  • CNVS 2000
  • Country
  • INDP United States
  • CNVS United States
  • Employees
  • INDP N/A
  • CNVS N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • CNVS Consumer Electronics/Video Chains
  • Sector
  • INDP Health Care
  • CNVS Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • CNVS Nasdaq
  • Market Cap
  • INDP 10.2M
  • CNVS 57.8M
  • IPO Year
  • INDP N/A
  • CNVS 2003
  • Fundamental
  • Price
  • INDP $0.94
  • CNVS $3.52
  • Analyst Decision
  • INDP Strong Buy
  • CNVS Buy
  • Analyst Count
  • INDP 2
  • CNVS 1
  • Target Price
  • INDP $8.50
  • CNVS $10.00
  • AVG Volume (30 Days)
  • INDP 25.8K
  • CNVS 208.8K
  • Earning Date
  • INDP 11-12-2024
  • CNVS 02-12-2025
  • Dividend Yield
  • INDP N/A
  • CNVS N/A
  • EPS Growth
  • INDP N/A
  • CNVS N/A
  • EPS
  • INDP N/A
  • CNVS N/A
  • Revenue
  • INDP N/A
  • CNVS $45,005,000.00
  • Revenue This Year
  • INDP N/A
  • CNVS $50.96
  • Revenue Next Year
  • INDP N/A
  • CNVS N/A
  • P/E Ratio
  • INDP N/A
  • CNVS N/A
  • Revenue Growth
  • INDP N/A
  • CNVS N/A
  • 52 Week Low
  • INDP $0.84
  • CNVS $0.72
  • 52 Week High
  • INDP $3.10
  • CNVS $4.19
  • Technical
  • Relative Strength Index (RSI)
  • INDP 40.51
  • CNVS 53.07
  • Support Level
  • INDP $0.94
  • CNVS $3.29
  • Resistance Level
  • INDP $1.01
  • CNVS $3.56
  • Average True Range (ATR)
  • INDP 0.06
  • CNVS 0.29
  • MACD
  • INDP 0.00
  • CNVS -0.09
  • Stochastic Oscillator
  • INDP 28.24
  • CNVS 40.90

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Share on Social Networks: